PCV40 - BUDGET IMPACT ANALYSIS OF RIVAROXABAN IN THE SECONDARY PREVENTION OF ACUTE CORONARY SYNDROMES IN GREECE
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.587
https://www.valueinhealthjournal.com/article/S1098-3015(18)33887-7/fulltext
Section Title :
Section Order :
2482
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33887-7&doi=10.1016/j.jval.2018.09.587